NORDIC BIOTECH K/S: Financial statements 2020
CVR: 26290724
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -1,360,000 compared with DKK 12,997,000 the year before. Equity in the 2020 report amounted to DKK 85,109,000. The solvency ratio was 99.9%.
- Profit/Loss
- DKK -1,360,000
- Equity
- DKK 85,109,000
- Total Assets
- DKK 85,170,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | -1.4M | 85.1M | 0 |
| 2019 | - | - | 13M | 86.5M | 0 |
| 2018 | - | - | -464.7M | 73.5M | - |
| 2017 | - | - | 149.6M | 538.1M | - |
| 2016 | - | - | -1.1B | 2.3B | - |
Official annual report
How creditworthy is NORDIC BIOTECH K/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NORDIC BIOTECH K/S has published its annual report for 2019. The net result was DKK 12,997,000.
About NORDIC BIOTECH K/S
NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.
